| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.24B | 94.91B | 88.48B | 82.84B | 78.44B | 67.09B |
| Gross Profit | 19.59B | 20.81B | 18.96B | 17.79B | 15.84B | 12.71B |
| EBITDA | 9.56B | 10.24B | 9.10B | 8.70B | 7.44B | 5.81B |
| Net Income | 5.22B | 6.08B | 4.78B | 4.34B | 4.27B | 2.68B |
Balance Sheet | ||||||
| Total Assets | 131.36B | 131.28B | 130.28B | 130.79B | 114.52B | 99.49B |
| Cash, Cash Equivalents and Short-Term Investments | 10.65B | 13.00B | 12.88B | 10.65B | 11.13B | 12.94B |
| Total Debt | 36.77B | 22.89B | 36.16B | 39.40B | 31.08B | 24.63B |
| Total Liabilities | 63.23B | 54.37B | 61.44B | 65.49B | 54.95B | 44.55B |
| Stockholders Equity | 67.91B | 76.67B | 68.61B | 65.03B | 59.18B | 54.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.04B | 7.46B | -7.84B | -8.13B | -4.62B |
| Operating Cash Flow | 0.00 | 16.55B | 9.43B | -4.59B | -5.69B | -3.44B |
| Investing Cash Flow | 0.00 | -3.76B | -2.02B | -2.23B | -2.06B | -1.08B |
| Financing Cash Flow | 0.00 | -12.98B | -5.59B | 5.87B | 5.10B | 4.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.99B | 11.99 | ― | 3.95% | 2.75% | 25.75% | |
79 Outperform | ¥134.05B | 16.49 | ― | 3.24% | 8.95% | 18.54% | |
71 Outperform | ¥92.61B | 14.50 | 9.39% | 1.68% | 7.26% | 28.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥23.04B | 74.98 | ― | 2.77% | -11.58% | -82.90% | |
52 Neutral | ¥85.27B | 27.20 | 5.02% | 3.23% | -21.03% | -91.77% | |
45 Neutral | ¥16.64B | 12.48 | ― | ― | -8.87% | ― |